美国NDC复合药物数据库文件

药品名称：商品名称：药品NDC：报告期内： -格式:2020-5-3
NDC包装id：市场分类：活性成分：持证企业：

美国NDC复合药物数据库文件4843条(本栏目更新到2026-3-31)

药品名称(分析)

商品名

药品NDC

专利人(分析)

报告期内

活性成分

市场分类

规格(分析)

NDC包装id

TESTOSTERONE 55 PEL

HUMAN COMPOUNDED DRUG

73271-0055

Right Value Drug Stores llc dba Carie Boyd Pharmaceuticals

2024-2

TESTOSTERONE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

55 mg

73271-0055-1

KETOCONAZOLE TOPICAL

HUMAN COMPOUNDED DRUG

73271-1213

Right Value Drug Stores llc dba Carie Boyd Pharmaceuticals

2024-2

KETOCONAZOLE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

.0217 g/1 g

73271-1213-1

Moxifloxacin

HUMAN COMPOUNDED DRUG

79926-068

Wedgewood Connect

2024-2

MOXIFLOXACIN HYDROCHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

1 mg/1 mL

79926-068-05

ESTRADIOL 12.5MG

HUMAN COMPOUNDED DRUG

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

12.5 mg

70713-051-01

Bupivacaine Hydrochloride with Epinephrine

HUMAN COMPOUNDED DRUG

71139-5350

IntegraDose Compounding Services, LLC

2024-2

EPINEPHRINE; BUPIVACAINE HYDROCHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

150 ug/30 mL; 150 mg/30 mL

71139-5350-1

CEFAZOLIN

HUMAN COMPOUNDED DRUG

71139-5330

IntegraDose Compounding Services, LLC

2024-2

CEFAZOLIN SODIUM

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

3 g/30 mL

71139-5330-2

CEFAZOLIN

HUMAN COMPOUNDED DRUG

71139-7087

IntegraDose Compounding Services, LLC

2024-2

CEFAZOLIN SODIUM

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

2 g/20 mL

71139-7087-1

Fentanyl Citrate CADD

HUMAN COMPOUNDED DRUG

71139-6030

IntegraDose Compounding Services, LLC

2024-2

FENTANYL CITRATE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

2500 ug/50 mL

71139-6030-1

Vasopressin

HUMAN COMPOUNDED DRUG

71139-0190

IntegraDose Compounding Services, LLC

2024-2

VASOPRESSIN, UNSPECIFIED

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

2 U/2 mL

71139-0190-1

Oxytocin

HUMAN COMPOUNDED DRUG

71139-0012

IntegraDose Compounding Services, LLC

2024-2

OXYTOCIN

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

30 U/500 mL

71139-0012-1

Hydromorphone HYDROCHLORIDE CADD

HUMAN COMPOUNDED DRUG

71139-0018

IntegraDose Compounding Services, LLC

2024-2

HYDROMORPHONE HYDROCHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

20 mg/100 mL

71139-0018-1

Maintenance 4 to1 Low K (12 meq) in Ringers

HUMAN COMPOUNDED DRUG

72196-0205

Central Admixture Pharmacy Services, Inc.

2024-2

MANNITOL; LIDOCAINE HYDROCHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; POTASSIUM CHLORIDE; CALCIUM CHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

31.26 g/504.8 mL; 250 mg/504.8 mL; .924 g/504.8 mL; 2.743 g/504.8 mL; .99 g/504.8 mL; .105 g/504.8 mL

72196-0205-1

Phenylephrine 40mg added to NS

HUMAN COMPOUNDED DRUG

72196-6092

Central Admixture Pharmacy Services, Inc.

2024-2

PHENYLEPHRINE HYDROCHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

40 mg/250 mL

72196-6092-1

Phenylephrine 25mg added to NS

HUMAN COMPOUNDED DRUG

72196-7011

Central Admixture Pharmacy Services, Inc.

2024-2

PHENYLEPHRINE HYDROCHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

25 mg/250 mL

72196-7011-1

Epinephrine 4mg added to NS

HUMAN COMPOUNDED DRUG

72196-8093

Central Admixture Pharmacy Services, Inc.

2024-2

EPINEPHRINE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

4 mg/250 mL

72196-8093-1

Vancomycin 2gm added to NS

HUMAN COMPOUNDED DRUG

72196-6078

Central Admixture Pharmacy Services, Inc.

2024-2

VANCOMYCIN HYDROCHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

2 g/500 mL

72196-6078-1

del Nido Plasmalyte-A

HUMAN COMPOUNDED DRUG

72196-0202

Central Admixture Pharmacy Services, Inc.

2024-2

MANNITOL; LIDOCAINE HYDROCHLORIDE; MAGNESIUM SULFATE HEPTAHYDRATE; MAGNESIUM CHLORIDE; SODIUM GLUCONATE; SODIUM ACETATE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM BICARBONATE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

3.26 g/1052.8 mL; 130 mg/1052.8 mL; 16.24 meq/1052.8 mL; .3 g/1052.8 mL; 5.02 g/1052.8 mL; 3.68 g/1052.8 mL; 2.307 g/1052.8 mL; 5.26 g/1052.8 mL; 1.092 g/1052.8 mL

72196-0202-1

Trophamine 3% / Dextrose 5% With Calcium Gluconate 3.75mEq and Heparin 125 units 250ml in 250ml bag

HUMAN COMPOUNDED DRUG

71285-0419

Central Admixture Pharmacy Services, Inc.

2024-2

ALANINE; GLYCINE; PHENYLALANINE; TRYPTOPHAN; VALINE; GLUTAMIC ACID; LYSINE ACETATE; SERINE; TYROSINE; N-ACETYLTYROSINE; THREONINE; CYSTEINE HYDROCHLORIDE; HISTIDINE; ARGININE; TAURINE; DEXTROSE MONOHYDRATE; LEUCINE; METHIONINE; PROLINE; ASPARTIC ACID; ISOLEUCINE; CALCIUM GLUCONATE MONOHYDRATE; HEPARIN SODIUM

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

.405 g/250 mL; .27 g/250 mL; .36 g/250 mL; .15 g/250 mL; .585 g/250 mL; .375 g/250 mL; .9 g/250 mL; .285 g/250 mL; .033 g/250 mL; .18 g/250 mL; .315 g/250 mL; .018 g/250 mL; .36 g/250 mL; .9 g/250 mL; .01875 g/250 mL; 12.5 g/250 mL; 1.05 g/250 mL; .255 g/250 mL; .51 g/250 mL; .24 g/250 mL; .615 g/250 mL; 3.75 meq/250 mL; 125 U/250 mL

71285-0419-1

del Nido Cardioplegia

HUMAN COMPOUNDED DRUG

69374-984

Nephron Sterile Compounding Center, LLC

2024-2

SODIUM BICARBONATE; LIDOCAINE HYDROCHLORIDE; POTASSIUM CHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

1.04 g/1 mL; 123 mg/1 mL; 2.19 g/1 mL

69374-984-10

Rocuronium Bromide 10 mg/mL

HUMAN COMPOUNDED DRUG

69374-924

Nephron Sterile Compounding Center, LLC

2024-2

ROCURONIUM BROMIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

10 mg/1 mL

69374-924-05

网站地图 - 网站开发 - 网站简介 - 会员服务 - 法律声明 - 联系我们 - 药品招商频道 - 药品信息排行 - 2018年版国家基本药物目录 - 意见反馈

浙ICP备16010490号-2 增值电信业务经营许可证：浙B2-20220931　互联网药品信息服务资格证书编号：(浙)-经营性2023-0215　

浙公网安备:330683240604819103159
　医药代理商群１：

医药代理商群２：

医药代理商群３：